"Myeloma Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA.
| Descriptor ID |
D009194
|
| MeSH Number(s) |
D12.776.124.486.485.900.500 D12.776.124.790.651.900.500 D12.776.377.715.548.900.500 D12.776.624.553
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myeloma Proteins".
Below are MeSH descriptors whose meaning is more specific than "Myeloma Proteins".
This graph shows the total number of publications written about "Myeloma Proteins" by people in this website by year, and whether "Myeloma Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myeloma Proteins" by people in Profiles.
-
Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma. Blood. 2024 08 29; 144(9):955-963.
-
Development of novel methods for non-canonical myeloma protein analysis with an innovative adaptation of immunofixation electrophoresis, native top-down mass spectrometry, and middle-down de novo sequencing. Clin Chem Lab Med. 2021 03 26; 59(4):653-661.
-
Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial. Leuk Lymphoma. 2011 Jul; 52(7):1271-80.
-
Interpretation of hypercalcemia in a patient with end-stage renal disease. Arch Intern Med. 1992 Jun; 152(6):1321-2.
-
IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance. Ann Clin Lab Sci. 1989 Jan-Feb; 19(1):27-37.
-
Transgenic mice with mu and kappa genes encoding antiphosphorylcholine antibodies. J Exp Med. 1986 Aug 01; 164(2):627-41.
-
Monoclonal antibody-based solid-phase immunoenzymometric assays for quantifying human immunoglobulin G and its subclasses in serum. Clin Chem. 1985 Dec; 31(12):1940-5.
-
Characterization of E-rosette-positive Fc-receptor-bearing cells by flow cytometry. Clin Immunol Immunopathol. 1982 Jan; 22(1):105-17.
-
Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature. 1981 Apr 16; 290(5807):562-5.
-
The structural basis of antigenic determinants on V kappa 21 light chains. Mol Immunol. 1981 Jan; 18(1):1-9.